BNET Industries

Provectus Pharmaceuticals Inc.

(PVCT) is in the Pharma Industry

Market Cap:$67.4M
Last Fiscal Year Sales:$1.3K
  • Public
  • US
Dow Jones Description

Provectus, and its five wholly owned subsidiaries: o Xantech Pharmaceuticals, Inc. o Pure-ific Corporation o Provectus Biotech, Inc. o Provectus Devicetech, Inc. o Provectus Pharmatech, Inc. (which we refer to as our subsidiaries) develop, license and market and plan to sell products in three sectors of the healthcare industry: o Over-the-counter products, which we refer to in this report as "OTC products;" o Prescription drugs; and o Medical device systems We manage Provectus and our subsidiaries on an integrated basis and when we refer to "we" or "us" or "the Company" in this Annual Report on Form 10-KSB, we refer to all six corporations considered as a single unit. Our principal executive offices are located at 7327 Oak Ridge Highway, Suite A, Knoxville, Tennessee 37931, telephone 865/769-4011. Through discovery and use of state-of-the-art scientific and medical technologies, the founders of our pharmaceutical business have developed a portfolio of patented, patentable, and proprietary technologies that support multiple products in the prescription drug, medical device and OTC products categories (including patented technologies for: (a) treatment of cancer; (b) novel therapeutic medical devices; (c) enhancing contrast in medical imaging; (d) improving signal processing during biomedical imaging; and (e) enhancing production of biotechnology products).

Number of Employees 7
Contact Information

7327 Oak Ridge Hwy

Suite B

Knoxville, Tennessee 37931

www.provectusco...

865-769-4011

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Provectus Initiates Phase 1 Trial of PV-10 for Liver Cancer

    10/05/09 - Bond / Stock Rating - View Story

News & Analysis

provectus pharmaceuticals inc. - All News and Analysis

advertisement
     PVCT $1.02 -0.05 (-4.67% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 166,263
Shares Outstanding 64.91M
Market Cap 66.2M
Year High 1.33
Year Low 0.675
Earnings Per Share -0.21
P/E Ratio -4.86
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here